Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
47.53M | 52.02M | 46.74M | 43.14M | 40.32M | 42.50M | Gross Profit |
20.41M | 23.78M | 16.55M | 18.61M | 20.97M | 20.92M | EBIT |
-5.26M | 1.13M | -5.70M | -5.59M | 2.10M | 1.13M | EBITDA |
-4.70M | 5.65M | 1.57M | -34.00K | 9.76M | 4.89M | Net Income Common Stockholders |
-5.42M | 561.00K | -3.29M | -4.94M | 3.54M | 771.00K |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
39.06M | 14.22M | 12.94M | 16.45M | 26.65M | 8.09M | Total Assets |
85.09M | 98.12M | 94.29M | 95.25M | 98.67M | 85.84M | Total Debt |
0.00 | 21.25M | 15.22M | 11.47M | 13.24M | 12.15M | Net Debt |
-39.06M | 7.03M | 2.28M | -4.98M | -13.41M | 4.05M | Total Liabilities |
3.19M | 27.70M | 24.68M | 21.34M | 20.20M | 21.39M | Stockholders Equity |
81.91M | 70.41M | 69.59M | 73.87M | 78.39M | 64.45M |
Cash Flow | Free Cash Flow | ||||
-2.80M | -1.28M | -2.12M | -5.55M | 7.67M | -3.11M | Operating Cash Flow |
-1.95M | -306.00K | -1.51M | -5.10M | 8.11M | -1.68M | Investing Cash Flow |
-1.02M | -949.00K | 4.18M | -2.16M | -236.00K | -4.42M | Financing Cash Flow |
4.91M | 2.79M | -5.75M | -3.03M | 10.48M | -2.86M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
66 Neutral | $4.50B | 12.28 | 5.32% | 248.52% | 4.13% | -12.36% | |
57 Neutral | HK$76.80M | ― | -8.09% | ― | -3.68% | -136.36% | |
$68.90M | ― | -14.00% | ― | ― | ― | ||
€1.08B | 8.12 | 7.85% | 6.90% | ― | ― | ||
77 Outperform | HK$556.66B | 5.47 | 10.41% | 5.52% | -1.43% | 5.12% | |
59 Neutral | HK$136.00M | 16.51 | 2.07% | 15.38% | -13.16% | -81.74% | |
54 Neutral | HK$2.04B | 3.43 | 11.49% | ― | 47.32% | 492.76% |